PTC Therapeutics (PTCT) stock on watch as company receives FDA approval for gene therapy Kebilidi for AADC deficiency. Read ...

Raising and narrowing 2024 guidance ranges: Adjusted EBITDA of $750 to $780 million and Adjusted Free Cash Flow of $265 to $285 million. Reaffirming 2025 guidance ranges: Adjusted EBITDA of $925 to $1 ...

Showers and a few noisy storms will rumble through North and Central Alabama through Thursday morning, but most of the rain will be over by 9 a.m. The coolest air of the month so far will follow that ...

If we were to see impacts from the disturbance, those impacts would occur Wednesday or perhaps even early Thursday of next week.Follow the ABC7 weather team on social mediaChief Meteorologist John ...

WARREN, NJ, USA I November 13, 2024 I PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the U.S. Food and Drug Administration (FDA) accelerated approval of its gene therapy for the treatment of ...

PTC Therapeutics (PTCT) announced that the FDA accelerated approval of its gene therapy for the treatment of AADC deficiency, the first-ever ...

Over 1,000 companies, including Muthoot Finance and Grasim, will release Q2FY24-25 results today. The Niva Bupa <a ...

ClearPoint Neuro (CLPT) “announced the U.S. Food and Drug Administration has granted marketing authorization for the SmartFlow Neuro ...

Since joining the news agency in 2022, her award-winning work includes coverage ... study suggests 3:56 AM UTC Future of ...

Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics' (PTCT.O), opens new tab gene ... coats in ...

A federal judge ruled Wednesday that a Federal Trade Commission lawsuit accusing Facebook owner Meta of holding an illegal ...

The 3 PM Wednesday advisory issued by the National Hurricane Center (NHC) has issued an outlook for Potential Tropical ...